#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	12354	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2187	555.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1427	1427	C	693	C	677	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23024	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3611	630.3	0	.	n	.	0	T695C	SNP	695	695	T	1058	1058	C	685	C,A	670,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23024	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3611	630.3	0	.	n	.	0	A1638G	SNP	1638	1638	A	2001	2001	G	700	G,A	684,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23024	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3611	630.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2334	2334	C	749	C	728	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23024	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3611	630.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2408	2408	A	729	A	714	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23024	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3611	630.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2960	2960	C	713	C	694	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1646	folP	855	855	100.0	folP.l15.c4.ctg.1	1664	97.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1102	1104	AGC	175;175;174	A;G;C	174;171;171	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4462	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3415	129.4	1	SNP	p	S91F	1	.	.	271	273	TTC	592	594	TTC	148;146;146	T;T;C	147;144;143	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4462	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3415	129.4	1	SNP	p	D95G	1	.	.	283	285	GGC	604	606	GGC	141;138;137	G;G;C	140;136;134	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4462	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3415	129.4	1	SNP	p	G95N	0	.	.	283	285	GGC	604	606	GGC	141;138;137	G;G;C	140;136;134	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1408	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1220	113.7	0	.	p	.	0	F184L	NONSYN	550	552	TTC	832	834	TTG	140;139;141	T;T;G,A	140;138;139,1	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1408	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1220	113.7	1	SNP	p	G45D	0	.	.	133	135	GGC	415	417	GGC	174;171;170	G;G;C	174;167;166	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	758	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	1009	74.2	0	.	n	.	0	A197.	DEL	197	197	A	587	587	A	162	A	161	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3954	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3006	129.8	1	SNP	p	D86N	0	.	.	256	258	GAC	620	622	GAC	174;173;175	G;A;C	171;169;174	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3954	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3006	129.8	1	SNP	p	S87R	1	.	.	259	261	CGT	623	625	CGT	176;177;177	C;G;T	176;175;173	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3954	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3006	129.8	1	SNP	p	R87W	0	.	.	259	261	CGT	623	625	CGT	176;177;177	C;G;T	176;175;173	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3954	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3006	129.8	1	SNP	p	R87I	0	.	.	259	261	CGT	623	625	CGT	176;177;177	C;G;T	176;175;173	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3954	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3006	129.8	1	SNP	p	S88P	0	.	.	262	264	TCC	626	628	TCC	177;176;175	T;C;C	175;173;173	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3444	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2668	127.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1504	1506	GGC	179;174;174	G;G;C	173;167;167	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3352	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2417	136.7	1	SNP	p	A311V	0	.	.	931	933	GCC	1303	1305	GCC	200;199;200	G,A;C;C	195,1;193;195	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3352	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2417	136.7	1	SNP	p	I312M	1	.	.	934	936	ATG	1306	1308	ATG	203;200;203	A;T;G	199;194;200	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3352	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2417	136.7	1	SNP	p	T316P	0	.	.	946	948	ACC	1318	1320	ACC	203;202;200	A;C,A;C,A	192;199,1;195,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3352	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2417	136.7	1	SNP	p	V316T	1	.	.	946	948	ACC	1318	1320	ACC	203;202;200	A;C,A;C,A	192;199,1;195,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3352	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2417	136.7	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1819	1821	ACC	145;145;148	A;C;C	133;141;144	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3352	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2417	136.7	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1873	1875	GCG	142;143;142	G;C;G	140;143;142	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3352	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2417	136.7	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1873	1875	GCG	142;143;142	G;C;G	140;143;142	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3352	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2417	136.7	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1996	1998	GGT	122;121;120	G;G;T	118;118;115	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3352	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2417	136.7	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2005	2007	AGC	108;107;105	A;G;C	107;107;102	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3352	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2417	136.7	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2023	2025	CCG	90;90;91	C;C,G;GCCC,GGCCCCC	83;82,1;76,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4658	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3130	146.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1663	1665	CCG	166;166;168	C;C;G	153;161;158	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1940	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1796	106.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	533	533	C	133	C,G	123,1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	264	porB1a	984	271	91.88	porB1a.l15.c30.ctg.1	416	18.3	0	.	p	.	0	V258L	NONSYN	772	774	GTA	64	66	TTA	35;36;36	T;T;A	35;36;36	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	264	porB1a	984	271	91.88	porB1a.l15.c30.ctg.1	416	18.3	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	109	111	CAT	36;36;36	C;A;T	35;36;36	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	264	porB1a	984	271	91.88	porB1a.l15.c30.ctg.1	416	18.3	0	.	p	.	0	D274S	NONSYN	820	822	GAT	112	114	AGT	36;36;36	A;G;T	35;36;35	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	264	porB1a	984	271	91.88	porB1a.l15.c30.ctg.1	416	18.3	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	121	123	TAC	36;36;36	T;A;C	36;36;34	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	264	porB1a	984	271	91.88	porB1a.l15.c30.ctg.1	416	18.3	0	.	p	.	0	R307A	NONSYN	919	921	AGA	211	213	GCA	11;11;11	G;C;A	11;10;10	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	264	porB1a	984	271	91.88	porB1a.l15.c30.ctg.1	416	18.3	0	.	p	.	0	T311A	NONSYN	931	933	ACA	223	225	GCA	12;12;12	G;C;A	12;12;11	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	264	porB1a	984	271	91.88	porB1a.l15.c30.ctg.1	416	18.3	0	.	p	.	0	E312D	NONSYN	934	936	GAA	226	228	GAC	12;12;12	G;A;C	11;12;12	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	264	porB1a	984	271	91.88	porB1a.l15.c30.ctg.1	416	18.3	0	.	p	.	0	F314I	NONSYN	940	942	TTC	232	234	ATC	13;12;12	A;T;C	12;12;10	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	264	porB1a	984	271	91.88	porB1a.l15.c30.ctg.1	416	18.3	0	.	p	.	0	A316S	NONSYN	946	948	GCG	238	240	TCG	12;12;11	T;C;G	10;12;8	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	264	porB1a	984	271	91.88	porB1a.l15.c30.ctg.1	416	18.3	0	.	p	.	0	V318A	NONSYN	952	954	GTC	244	246	GCC	9;8;8	G;C;C	7;8;8	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	264	porB1a	984	271	91.88	porB1a.l15.c30.ctg.1	416	18.3	0	.	p	.	0	G319S	NONSYN	955	957	GGC	247	249	AGC	8;8;8	A;G;C	6;8;8	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	264	porB1a	984	271	91.88	porB1a.l15.c30.ctg.1	416	18.3	0	.	p	.	0	G320A	NONSYN	958	960	GGT	250	252	GCC	8;9;9	G;C;C	6;8;9	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	264	porB1a	984	271	91.88	porB1a.l15.c30.ctg.1	416	18.3	0	.	p	.	0	G322V	NONSYN	964	966	GGT	256	258	GTT	7;7;7	G;T;T	6;6;6	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2356	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1611	144.4	0	.	p	.	0	N38E	NONSYN	112	114	AAT	531	533	GAA	164;164;162	G;A;A	158;161;158	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2356	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1611	144.4	0	.	p	.	0	N134D	NONSYN	400	402	AAT	819	821	GAT	184;183;184	G,A;A,T;T	178,1;178,1;179	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2356	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1611	144.4	0	.	p	.	0	P175S	NONSYN	523	525	CCA	942	944	TCA	171;170;169	T;C;A	170;167;167	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2356	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1611	144.4	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1071	1073	GTC	204;208;205	G;T;C	198;202;202	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2356	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1611	144.4	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1083	1085	TCT	204;205;205	T;C,T;T	199;201,1;200	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2356	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1611	144.4	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1401	1403	GCA	191;189;193	G;C;A	188;184;186	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2356	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1611	144.4	1	SNP	p	G120K	1	.	.	358	360	AAG	777	779	AAG	167;165;163	A,G;A,G;G,T	164,1;162,1;156,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2356	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1611	144.4	1	SNP	p	D121N	0	.	.	361	363	GAC	780	782	GAC	163;161;159	G,A;A,C;C	157,1;155,1;156	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2356	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1611	144.4	1	SNP	p	A121D	1	.	.	361	363	GAC	780	782	GAC	163;161;159	G,A;A,C;C	157,1;155,1;156	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	7876	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5076	153.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	916	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1179	77.0	1	SNP	p	V57M	1	.	.	169	171	ATG	583	585	ATG	181;181;178	A;T;G	177;178;173	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
